Refractory familial hypokalaemic periodic paralysis leading to cardiovascular compromise.
Dominic O AwuahMurtaza S HussainAnoosha PonnapalliSmit Sunil DeliwalaElfateh M SeedahmedGhassan BachuwaPublished in: BMJ case reports (2022)
Familial hypokalaemic periodic paralysis (FHPP) is a rare neuromuscular disorder that is classified under periodic paralysis (PP), which is characterised by episodes of muscle weakness. Common triggers include intense exercise, fasting or consumption of carbohydrate-rich meals. Hypokalaemic PP has an incidence of 1 in 100 000; despite the temporal association, cardiac manifestations are exceedingly rare. We present a case of FHPP, a channelopathy presenting with severe refractory hypokalaemia. The challenges with our patient were maintaining potassium levels within normal ranges and initiating a close follow-up plan. Due to the lack of clinical guidance in our case, many aspects of care, including surveillance, medications and genetic testing, remain unaddressed. Medical management includes aggressive correction with supplements, potassium-sparing diuretics and carbonic anhydrase inhibitors. Severe cases of dysrhythmias, especially ventricular fibrillation, require electrophysiology evaluation and possible implantation of a defibrillator to prevent sudden cardiac death.
Keyphrases
- early onset
- healthcare
- left ventricular
- case report
- public health
- heart failure
- palliative care
- skeletal muscle
- risk factors
- insulin resistance
- physical activity
- blood glucose
- pain management
- blood pressure
- cardiac resynchronization therapy
- adipose tissue
- metabolic syndrome
- resistance training
- body composition
- atrial fibrillation
- catheter ablation